Facebook Tracking Image

National Comprehensive Cancer Network

About NCCN

NCCN Flash Updates: NCCN Guidelines®, NCCN Compendium®, and the NCCN Imaging AUC™ for Anal Carcinoma

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), NCCN Drugs & Biologics Compendium (NCCN Compendium®), and the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) for Anal Carcinoma. These NCCN Guidelines® are currently available as Version 1.2020.

  • Anal Canal Cancer (ANAL-1)
    • “Consider fertility risk discussion/counseling in appropriate patients” was added to Workup. Also for ANAL-2.
    • Modified docetaxel/cisplatin/fluorouracil (category 2B) was added as a treatment option for metastatic disease. Also for ANAL-2, ANAL-3, and ANAL-4.
  • Follow-up and Surveillance (ANAL-3)
    • Surveillance for complete remission, 4th bullet was updated: Chest/abdominal/pelvic CT with contrast or chest CT without contrast and abdominal/pelvic CT or MRI with contrast annually for 3 y.
    • “± RT” was removed from treatment of metastatic disease. Also for ANAL-4.
    • Surveillance: “with contrast” was added to abdominal/pelvic MRI. Also for ANAL-4.
    • Footnote k is new: “Palliative RT may be considered in symptomatic patients. Records of previous RT should be carefully reviewed and considered prior to potential re-irradiation of previously irradiated fields. See Principles of Radiation Therapy (ANAL-C).” Also for ANAL-4.
  • Principles of Systemic Therapy (ANAL-B)
    • A second dosing option was added for carboplatin + paclitaxel with appropriate reference:
      Carboplatin AUC 5 IV day 1
      Paclitaxel 80 mg/m2 IV day 1, 8, 15
      Repeat every 28 days
    • Dosing for Modified DCF was added with appropriate reference.
      Docetaxel 40 mg/m2 IV day 1
      Cisplatin 40 mg/m2 IV day 1
      Fluorouracil 1200 mg/m2/day x 2 days
      (total 2400 mg/m2 over 46–48 hours)
      Repeat every 2 weeks
    • References have been updated.
  • Principles of Radiation Therapy (ANAL-C)
    • Table 1 and Table 2 are new.

 

For the complete updated versions of the NCCN Guidelines, NCCN Guidelines with NCCN Evidence Blocks™, the NCCN Drugs & Biologics Compendium (NCCN Compendium®), the NCCN Biomarkers Compendium®, the NCCN Chemotherapy Order Templates (NCCN Templates®), the NCCN Radiation Therapy Compendium™, and the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™), please visit NCCN.org.

To view the NCCN Guidelines for Patients®, please visit NCCN.org/patientguidelines.

Free NCCN Guidelines apps for iPhone, iPad, and Android devices are now available! Visit NCCN.org/apps.

About NCCN Flash Updates™

NCCN Flash Updates™ is a subscription service from NCCN that provides timely notification of updated and new information appearing in the NCCN Guidelines, the NCCN Compendium®, and other NCCN Content.

Subscribe to NCCN Flash Updates™

Please note: The NCCN Third Party Content FTP site: ftp://ftp1.nccn.org/ThirdPartyContent/ has been updated. Licensees are solely responsible for obtaining permission from such third party to use any such Third Party Content in the Permitted Works.

Access information on permissions and licensing of NCCN Content

Users may unsubscribe from Flash Updates at any time by contacting us. NOTE: The subscription fee for NCCN Flash Updates™ is non-refundable.